Table A1.
Classes and biomarkers, and risk of bias assessment included in this review.
| Classes | Types | Risk of Bias | |
|---|---|---|---|
| Reactive Species | Reactive Nitrogen Species | Unclear | |
| Oxidative Enzymes | Xanthine Dehydrogenase (XDH) | Unclear | |
| Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase | Unclear | ||
| Superoxide Dismutase (SOD) | High risk | ||
| Inducible Nitric Oxide Synthase (iNOS) | High risk | ||
| Myeloperoxidase (MPO) | Unclear | ||
| Antioxidative Enzymes and Transcriptional Factors | Glutathione Peroxidase (GPx) | Low risk | |
| Glutathione Reductase (GSR) | High risk | ||
| Catalase | High risk | ||
| Xanthine oxidase (XO)-Uric Acid | Unclear | ||
| Nuclear Factor Erythroid 2-Related Factor (Nrf2) | Unclear | ||
| Peroxisome proliferator-activated receptors (PPARs) | Unclear | ||
| Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) | Unclear | ||
| Degradation Products and End Products | Protein | Protein carbonyls | Low risk |
| 3-nitrotyrosin (3-NO-Tyr) | High risk | ||
| Protein glutathionylation | Unclear | ||
| Dityrosine | Unclear | ||
| Advanced oxidation protein products (AOPPs) | High risk | ||
| Advanced glycation end products (AGEs) | High risk | ||
| Amino acids | Asymmetric dimethylarginine (ADMA) | Unclear | |
| Lipid | F2-isoprostane (F2-isoP) | Low risk | |
| Malondialdehyde (MDA) | Low risk | ||
| 4-hydroxynonenal (4-HNE) | Unclear | ||
| Hydroxyoctadecadienoic acid (HODE) | Unclear | ||
| Oxysterol | Unclear | ||
| DNA | 8-dihydro-2′deoxyguanosine (8-oxodG) | Unclear | |